Anxiety disorders affect as many as 30% of children and adolescents, and the children of parents with an anxiety disorder have a higher risk of developing an anxiety disorder than the children of parents [...]
Commonly Used Screening Tools May Not Identify Women with Perinatal Anxiety Disorders In 2015, the American College of Obstetricians and Gynecologists issued a committee opinion recommending that clinicians screen patients at least once during [...]
Anxiety disorders affect nearly 1 in 5 adults in the United States, and women are about twice as likely as men to suffer from an anxiety disorder at some point in their lifetime. According to [...]
While numerous published studies have investigated the impact of treatments for major depressive disorder (MDD) in pregnancy on maternal and neonatal outcomes, few studies have examined the perinatal effects of anxiety disorders such as generalized [...]
A significant number of women experience anxiety symptoms during pregnancy, with nearly 10% of women meeting criteria for generalized anxiety disorder. Even more women suffer from milder anxiety symptoms or what some refer to as [...]
The Edinburgh Postnatal Depression Scale (EPDS) was designed to screen women for postnatal depression. Cox and Holden (2003) state that the EPDS was not designed to measure anxiety. However, recent emphasis on the importance of recognizing symptoms of perinatal anxiety disorders, coupled with findings in research, have led to the suggestion that the EPDS may be used as a multidimensional tool to screen for anxiety disorders in addition to depression during the perinatal period (Matthey et al, 2012).
While most agree that there is a need for improved detection of anxiety and mood disorders in pregnant and postpartum women, there remain questions regarding the best instruments to use for screening. The Edinburgh Postnatal Depression Scale (a questionnaire consisting of 10 items) has long been used to screen women for postpartum depression (PPD); however, it is unclear how well these questions could be incorporated into larger surveillance programs, such as the CDC-sponsored Pregnancy Risk Assessment Monitoring System (PRAMS) which was designed to assess health behaviors and to screen for health problems, including depression and anxiety, in pregnant and postpartum women.